Naloxone Rescue: The Emerging Role of Pharmacists in Preventing Opioid Overdose

This activity is supported by an educational grant from Adapt Pharma.

Naloxone Rescue: The Emerging Role of Pharmacists in Preventing Opioid Overdose

Faculty

Patrick Bridgeman, PharmD, BCPS

Clinical Assistant Professor

Ernest Mario School of Pharmacy

Department of Pharmacy Practice and Administration

Clinical Pharmacy Specialist

Emergency Medicine

Robert Wood Johnson University Hospital

New Brunswick, New Jersey

Editorial Support

Jeannette Y. Wick, RPh, MBA, FASCP

Freelance Medical Writer

Arlington, Virginia

Visiting Professor

University of Connecticut School of Pharmacy

Storrs, Connecticut

Educational Objectives

After completing this continuing education program, the participant will be able to:

• Examine the prevalence of opioid overdose and its implications for society.
• Explore strategies and legislation aimed at reducing the growth of opioid-related overdoses and identify at-risk patients to ensure these strategies are aimed at the right audience.
• Explain the mechanism of action of naloxone, its role as an opiate antagonist, and its safety and efficacy profile.
• Distinguish the differences between the intravenous, intramuscular/subcutaneous, and intranasal routes of administration for naloxone.
• Illustrate the pharmacist’s role in educating patients about naloxone, including the role of the pharmacist in dispensing naloxone without a prescription.

Target audience: Retail P

harmacists

Type of activity: Application

Release date: March 7, 2016

Expiration date: March 7, 2017

Estimated time to complete activity: 2.0 hours

Fee: Free

Pharmacy Times Continuing Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-16-020-H01-P. The activity is available for CE credit through March 7, 2018.